NCT00413946View on ClinicalTrials.gov

Does Erythropoietin Improve Outcome in Very Preterm Infants?

PHASE2CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Intracranial HemorrhagePeriventricular LeukomalaciaCerebral PalsyDevelopmental Psychomotor Disorders
Interventions
DRUG

Recombinant human Erythropoietin

3 doses 3000 units (1 ml) of recombinant human erythropoietin per kg body weight

DRUG

saline

three doses of 1.0 ml saline per body weight

Trial Locations (5)

Unknown

Kantonsspital, Aarau

Kantonsspital, Basel

Kantonsspital, Chur

Hopital universitaire, Geneva

CH-8091

University Hospital, Zurich

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

Swiss Neonatal Network

NETWORK

NCT00413946 - Does Erythropoietin Improve Outcome in Very Preterm Infants? | Biotech Hunter | Biotech Hunter